Shah, M.K., Shah, M.A. and Shah, S.D. 2019. Risk of hypertension with bevacizumab, an antibody against vascular endothelial growth factor A: a systematic review and meta-analysis. International Journal of Basic & Clinical Pharmacology. 8, 10 (Sep. 2019), 2354–2360. DOI:https://doi.org/10.18203/2319-2003.ijbcp20194287.